This guidance for the management of patients with Hymenoptera venom allergy has been prepared by the Standards of Care Committee (SOCC) of the British Society for Allergy and Clinical Immunology (BSACI). The guideline is based on evidence as well as on expert opinion and is for use by both adult physicians and paediatricians practising allergy. During the development of these guidelines, all BSACI members were included in the consultation process using a web-based system. Their comments and suggestions were carefully considered by the SOCC. Where evidence was lacking, a consensus was reached by the experts on the committee. Included in this guideline are epidemiology, risk factors, clinical features, diagnostic tests, the natural history of Hymenoptera venom allergy and guidance on undertaking venom immunotherapy (VIT). There are also separate sections on children, elevated baseline tryptase and mastocytosis and mechanisms underlying VIT. Finally, we have made recommendations for potential areas of future research.
ACE inhibitor, anaphylaxis, baseline tryptase, bee, beta-blocker, hornet, Hymenoptera, IgE, immunotherapy, venom, wasp. Submitted 5 March 2011; revised 1 April 2011; accepted 29 April 2011.
MT Krishna; PW Ewan; L Diwakar; SR Durham; AJ Frew; SC. Leech and SM Nasser